Advertisement
Screener

Imunon, Inc. (IMNN) Operating Expenses

2.8 / 5 stars · 68/120 Roast Me

Imunon, Inc. Operating Expenses

Imunon, Inc. (IMNN) reported Operating Expenses of $2.79 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:OperatingExpenses · last filed 2026-08-11

  • Imunon, Inc. operating expenses for the quarter ending 2026-06-30 was $2.79M, a 0.86% increase year-over-year.
  • Imunon, Inc. operating expenses for the quarter ending 2026-03-31 was $4.31M, a 3.89% increase year-over-year.
  • Imunon, Inc. operating expenses for the quarter ending 2025-12-31 was $4.26M, a 2.79% increase year-over-year.
  • Imunon, Inc. operating expenses for the quarter ending 2025-09-30 was $3.48M, a 29.94% decline year-over-year.
  • Imunon, Inc. operating expenses for fiscal 2025 was $14.65M, a 23.42% decline from fiscal 2024.
  • Imunon, Inc. operating expenses for fiscal 2024 was $19.13M, a 9.02% decline from fiscal 2023.
  • Imunon, Inc. operating expenses for fiscal 2023 was $21.03M, a 17.27% decline from fiscal 2022.
  • Imunon, Inc. operating expenses for fiscal 2022 was $25.42M, a 18.20% increase from fiscal 2021.
Period endOperating Expenses 3 monthOperating Expenses 3 month as first filedOperating Expenses 6 monthOperating Expenses 9 monthOperating Expenses 12 month
2026-06-30$2.79M
10-Q · filed 2026-08-11
$7.10M
10-Q · filed 2026-08-11
$11.36M
derived: sum of 3 quarters · filed 2026-08-11
$14.84M
derived: sum of 4 quarters · filed 2026-08-11
2026-03-31$4.31M
10-Q · filed 2026-05-12
$8.57M
derived: sum of 2 quarters · filed 2026-05-12
$12.04M
derived: sum of 3 quarters · filed 2026-05-12
$14.81M
derived: sum of 4 quarters · filed 2026-08-11
2025-12-31$4.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$7.74M
derived: sum of 2 quarters · filed 2026-03-31
$10.51M
derived: sum of 3 quarters · filed 2026-08-11
$14.65M
10-K · filed 2026-03-31
2025-09-30$3.48M
10-Q · filed 2025-11-13
$6.24M
derived: sum of 2 quarters · filed 2026-08-11
$10.39M
10-Q · filed 2025-11-13
$14.54M
derived: sum of 4 quarters · filed 2026-08-11
2025-06-30$2.77M
10-Q · filed 2026-08-11
$6.91M
10-Q · filed 2026-08-11
$11.06M
derived: sum of 3 quarters · filed 2026-08-11
$16.02M
derived: sum of 4 quarters · filed 2026-08-11
2025-03-31$4.15M
10-Q · filed 2026-05-12
$8.29M
derived: sum of 2 quarters · filed 2026-05-12
$13.25M
derived: sum of 3 quarters · filed 2026-05-12
$18.27M
derived: sum of 4 quarters · filed 2026-05-12
2024-12-31$4.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31
$9.11M
derived: sum of 2 quarters · filed 2026-03-31
$14.12M
derived: sum of 3 quarters · filed 2026-03-31
$19.13M
10-K · filed 2026-03-31
2024-09-30$4.96M
10-Q · filed 2025-11-13
$9.97M
derived: sum of 2 quarters · filed 2025-11-13
$14.99M
10-Q · filed 2025-11-13
$20.95M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30$5.01M
10-Q · filed 2025-08-05
$10.02M
10-Q · filed 2025-08-05
$15.99M
derived: sum of 3 quarters · filed 2025-08-05
$19.90M
derived: sum of 4 quarters · filed 2025-08-05
2024-03-31$5.01M
10-Q · filed 2025-05-12
$10.98M
derived: sum of 2 quarters · filed 2025-05-12
$14.88M
derived: sum of 3 quarters · filed 2025-05-12
$20.36M
derived: sum of 4 quarters · filed 2025-05-12
2023-12-31$5.97M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$9.87M
derived: sum of 2 quarters · filed 2025-02-27
$15.35M
derived: sum of 3 quarters · filed 2025-02-27
$21.03M
10-K · filed 2025-02-27
2023-09-30$3.90M
10-Q · filed 2024-11-07
$9.38M
derived: sum of 2 quarters · filed 2024-11-07
$15.06M
10-Q · filed 2024-11-07
$22.11M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30$5.47M
10-Q · filed 2024-08-14
$11.16M
10-Q · filed 2024-08-14
$18.21M
derived: sum of 3 quarters · filed 2024-08-14
$24.51M
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31$5.68M
10-Q · filed 2024-05-13
$12.74M
derived: sum of 2 quarters · filed 2024-05-13
$19.04M
derived: sum of 3 quarters · filed 2024-05-13
$25.14M
derived: sum of 4 quarters · filed 2024-05-13
2022-12-31$7.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
$13.35M
derived: sum of 2 quarters · filed 2024-03-28
$19.45M
derived: sum of 3 quarters · filed 2024-03-28
$25.42M
10-K · filed 2024-03-28
2022-09-30$6.30M
10-Q · filed 2023-11-14
$12.40M
derived: sum of 2 quarters · filed 2023-11-14
$18.37M
10-Q · filed 2023-11-14
$23.99M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$6.10M
10-Q · filed 2023-08-10
$12.07M
10-Q · filed 2023-08-10
$17.69M
derived: sum of 3 quarters · filed 2023-08-10
$22.87M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31$5.97M
10-Q · filed 2023-05-11
$11.58M
derived: sum of 2 quarters · filed 2023-05-11
$16.77M
derived: sum of 3 quarters · filed 2023-05-11
$21.97M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$5.62M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30
$10.80M
derived: sum of 2 quarters · filed 2023-03-30
$16.00M
derived: sum of 3 quarters · filed 2023-03-30
$21.51M
10-K · filed 2023-03-30
2021-09-30$5.19M
10-Q · filed 2022-11-14
$10.38M
derived: sum of 2 quarters · filed 2022-11-14
$15.89M
10-Q · filed 2022-11-14
$20.81M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$5.20M
10-Q · filed 2022-08-15
$10.70M
10-Q · filed 2022-08-15
$15.62M
derived: sum of 3 quarters · filed 2022-08-15
$19.91M
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31$5.51M
10-Q · filed 2022-05-16
$10.43M
derived: sum of 2 quarters · filed 2022-05-16
$14.71M
derived: sum of 3 quarters · filed 2022-05-16
$19.60M
derived: sum of 4 quarters · filed 2022-05-16
2020-12-31$4.92M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
$9.20M
derived: sum of 2 quarters · filed 2022-03-31
$14.10M
derived: sum of 3 quarters · filed 2022-03-31
$18.99M
10-K · filed 2022-03-31
2020-09-30$4.28M
10-Q · filed 2021-11-15
$9.18M
derived: sum of 2 quarters · filed 2021-11-15
$14.07M
10-Q · filed 2021-11-15
$18.94M
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30$4.89M
10-Q · filed 2021-08-12
$9.78M
10-Q · filed 2021-08-12
$14.66M
derived: sum of 3 quarters · filed 2021-08-12
$20.17M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$4.89M
10-Q · filed 2021-05-14
$9.76M
derived: sum of 2 quarters · filed 2021-05-14
$15.28M
derived: sum of 3 quarters · filed 2021-05-14
$20.97M
derived: sum of 4 quarters · filed 2021-05-14
2019-12-31$4.87M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19
$10.39M
derived: sum of 2 quarters · filed 2021-03-19
$16.08M
derived: sum of 3 quarters · filed 2021-03-19
$21.07M
10-K · filed 2021-03-19
2019-09-30$5.51M
10-Q · filed 2020-11-16
$11.21M
derived: sum of 2 quarters · filed 2020-11-16
$16.19M
10-Q · filed 2020-11-16
$21.07M
derived: sum of 4 quarters · filed 2020-11-16
2019-06-30$5.69M
10-Q · filed 2020-08-14
$10.68M
10-Q · filed 2020-08-14
$15.56M
derived: sum of 3 quarters · filed 2020-08-14
$19.70M
derived: sum of 4 quarters · filed 2020-08-14
2019-03-31$4.99M
10-Q · filed 2020-05-15
$9.86M
derived: sum of 2 quarters · filed 2020-05-15
$14.01M
derived: sum of 3 quarters · filed 2020-05-15
$22.14M
derived: sum of 4 quarters · filed 2020-05-15
2018-12-31$4.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25
$9.02M
derived: sum of 2 quarters · filed 2020-03-25
$17.16M
derived: sum of 3 quarters · filed 2020-03-25
$21.57M
10-K · filed 2020-03-25
2018-09-30$4.15M
10-Q · filed 2019-11-14
$12.28M
derived: sum of 2 quarters · filed 2019-11-14
$16.69M
10-Q · filed 2019-11-14
$21.50M
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30$8.14M
10-Q · filed 2019-08-14
$12.54M
10-Q · filed 2019-08-14
$17.35M
derived: sum of 3 quarters · filed 2019-08-14
$21.87M
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31$4.41M
10-Q · filed 2019-05-15
$9.21M
derived: sum of 2 quarters · filed 2019-05-15
$13.74M
derived: sum of 3 quarters · filed 2019-05-15
$18.26M
derived: sum of 4 quarters · filed 2019-05-15
2017-12-31$4.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
$9.33M
derived: sum of 2 quarters · filed 2019-03-29
$13.85M
derived: sum of 3 quarters · filed 2019-03-29
$18.97M
10-K · filed 2019-03-29
2017-09-30$4.52M
10-Q · filed 2017-11-14
$9.05M
derived: sum of 2 quarters · filed 2018-11-14
$14.16M
10-Q · filed 2018-11-14
$19.25M
derived: sum of 4 quarters · filed 2018-11-14
2017-06-30$4.52M
10-Q · filed 2018-11-14
$4.70M
10-Q · filed 2017-08-14
$9.64M
10-Q · filed 2018-08-14
$14.73M
derived: sum of 3 quarters · filed 2018-11-14
$20.45M
derived: sum of 4 quarters · filed 2018-11-14
2017-03-31$4.94M
10-Q · filed 2018-05-11
$10.20M
derived: sum of 2 quarters · filed 2018-05-11
$15.92M
derived: sum of 3 quarters · filed 2018-05-11
$20.79M
derived: sum of 4 quarters · filed 2018-05-11
2016-12-31$5.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-27
$10.98M
derived: sum of 2 quarters · filed 2018-03-27
$15.85M
derived: sum of 3 quarters · filed 2018-03-27
$21.15M
10-K · filed 2018-03-27
2016-09-30$5.72M
10-Q · filed 2017-11-14
$10.59M
derived: sum of 2 quarters · filed 2017-11-14
$15.89M
10-Q · filed 2017-11-14
$20.96M
derived: sum of 4 quarters · filed 2017-11-14
2016-06-30$4.87M
10-Q · filed 2017-08-14
$10.17M
10-Q · filed 2017-08-14
$15.24M
derived: sum of 3 quarters · filed 2017-08-14
$19.61M
derived: sum of 4 quarters · filed 2017-08-14
2016-03-31$5.30M
10-Q · filed 2017-05-12
$10.38M
derived: sum of 2 quarters · filed 2017-05-12
$14.74M
derived: sum of 3 quarters · filed 2017-05-12
$20.11M
derived: sum of 4 quarters · filed 2017-05-12
2015-12-31$5.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24
$9.44M
derived: sum of 2 quarters · filed 2017-03-24
$14.81M
derived: sum of 3 quarters · filed 2017-03-24
$21.35M
10-K · filed 2017-03-24
2015-09-30$4.37M
10-Q · filed 2016-11-10
$9.74M
derived: sum of 2 quarters · filed 2016-11-10
$16.27M
10-Q · filed 2016-11-10
$22.83M
derived: sum of 4 quarters · filed 2016-11-10
2015-06-30$5.37M
10-Q · filed 2016-08-15
$11.91M
10-Q · filed 2016-08-15
$18.46M
derived: sum of 3 quarters · filed 2016-08-15
$25.26M
derived: sum of 4 quarters · filed 2016-08-15
2015-03-31$6.54M
10-Q · filed 2016-05-16
$13.09M
derived: sum of 2 quarters · filed 2016-05-16
$19.89M
derived: sum of 3 quarters · filed 2016-05-16
$26.43M
derived: sum of 4 quarters · filed 2016-05-16
2014-12-31$6.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
$13.35M
derived: sum of 2 quarters · filed 2016-03-30
$19.89M
derived: sum of 3 quarters · filed 2016-03-30
$25.22M
10-K · filed 2016-03-30
2014-09-30$6.79M
10-Q · filed 2015-11-05
$13.33M
derived: sum of 2 quarters · filed 2015-11-05
$18.66M
10-Q · filed 2015-11-05
$22.05M
derived: sum of 4 quarters · filed 2016-03-30
2014-06-30$6.54M
10-Q · filed 2015-08-10
$11.86M
10-Q · filed 2015-08-10
$15.25M
derived: sum of 3 quarters · filed 2016-03-30
$18.91M
derived: sum of 4 quarters · filed 2016-03-30
2014-03-31$5.33M
10-Q · filed 2015-05-11
$8.71M
derived: sum of 2 quarters · filed 2016-03-30
$12.37M
derived: sum of 3 quarters · filed 2016-03-30
$16.35M
derived: sum of 4 quarters · filed 2016-03-30
2013-12-31$3.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
$7.05M
derived: sum of 2 quarters · filed 2016-03-30
$11.02M
derived: sum of 3 quarters · filed 2016-03-30
$15.91M
10-K · filed 2016-03-30
2013-09-30$3.66M
10-Q · filed 2014-11-10
$7.63M
derived: sum of 2 quarters · filed 2014-11-10
$12.52M
10-Q · filed 2014-11-10
$17.74M
derived: sum of 4 quarters · filed 2015-03-12
2013-06-30$3.97M
10-Q · filed 2014-08-07
$8.87M
10-Q · filed 2014-08-07
$14.08M
derived: sum of 3 quarters · filed 2015-03-12
$19.04M
derived: sum of 4 quarters · filed 2015-03-12
2013-03-31$4.89M
10-Q · filed 2014-05-08
$10.10M
derived: sum of 2 quarters · filed 2015-03-12
$15.06M
derived: sum of 3 quarters · filed 2015-03-12
$20.77M
derived: sum of 4 quarters · filed 2015-03-12
2012-12-31$5.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12
$10.17M
derived: sum of 2 quarters · filed 2015-03-12
$15.88M
derived: sum of 3 quarters · filed 2015-03-12
$22.14M
10-K · filed 2015-03-12
2012-09-30$4.96M
10-Q · filed 2013-11-12
$10.67M
derived: sum of 2 quarters · filed 2013-11-12
$16.93M
10-Q · filed 2013-11-12
$23.32M
derived: sum of 4 quarters · filed 2014-03-13
2012-06-30$5.71M
10-Q · filed 2013-08-08
$11.97M
10-Q · filed 2013-08-08
$18.36M
derived: sum of 3 quarters · filed 2014-03-13
$25.18M
derived: sum of 4 quarters · filed 2014-03-13
2012-03-31$6.26M
10-Q · filed 2013-05-09
$12.65M
derived: sum of 2 quarters · filed 2014-03-13
$19.47M
derived: sum of 3 quarters · filed 2014-03-13
$25.72M
derived: sum of 4 quarters · filed 2014-03-13
2011-12-31$6.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13
$13.21M
derived: sum of 2 quarters · filed 2014-03-13
$19.45M
derived: sum of 3 quarters · filed 2014-03-13
$25.02M
10-K · filed 2014-03-13
2011-09-30$6.82M
10-Q · filed 2012-11-09
$13.07M
derived: sum of 2 quarters · filed 2012-11-09
$18.63M
10-Q · filed 2012-11-09
$24.06M
derived: sum of 4 quarters · filed 2013-03-18
2011-06-30$6.25M
10-Q · filed 2012-08-14
$11.81M
10-Q · filed 2012-08-14
$17.24M
derived: sum of 3 quarters · filed 2013-03-18
$22.41M
derived: sum of 4 quarters · filed 2013-03-18
2011-03-31$5.56M
10-Q · filed 2012-05-15
$10.99M
derived: sum of 2 quarters · filed 2013-03-18
$16.16M
derived: sum of 3 quarters · filed 2013-03-18
$20.63M
derived: sum of 4 quarters · filed 2013-03-18
2010-12-31$5.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
$10.60M
derived: sum of 2 quarters · filed 2013-03-18
$15.06M
derived: sum of 3 quarters · filed 2013-03-18
$19.64M
10-K · filed 2013-03-18
2010-09-30$5.17M
10-Q · filed 2011-11-10
$9.64M
derived: sum of 2 quarters · filed 2011-11-10
$14.21M
10-Q · filed 2011-11-10
2010-06-30$4.46M
10-Q · filed 2011-08-09
$9.04M
10-Q · filed 2011-08-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
SOLIGENIX, INC. (SNGX)United States$0.008B
EXICURE, INC. (XCUR)United States$0.008B-1.54
Traws Pharma, Inc. (TRAW)United States$0.009B-0.58
Alzamend Neuro, Inc. (ALZN)United States$0.009B
Ensysce Biosciences, Inc. (ENSC)United States$0.008B-0.37
InMed Pharmaceuticals Inc. (INM)$0.008B-0.65
Apimeds Pharmaceuticals US, Inc. (APUS)United States$0.008B
FibroBiologics, Inc. (FBLG)United States$0.009B-0.27
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B
Acurx Pharmaceuticals, Inc. (ACXP)United States$0.007B-0.97